A Review of the ‘Gliptin’ Diabetes Drugs
Find out why you should not use any of the three recently-approved diabetes drugs known as "gliptins".

FDA's About-Face on Financial Conflicts of Interest
Last year, FDA Commissioner Dr. Margaret Hamburg told an audience at our D.C. Headquarters that FDA needed to allow more people with drug industry financial conflicts in order to get enough qualified doctors to fill its advisory committees. Find out why she was wrong and how she backed off this dangerous idea.

Risk of Bleeding and Use of Antidepressants After Heart Attack
The article discusses why taking certain antidepressants after a heart attack may increase the risk of bleeding. Find out which ones are the culprits.

Sitagliptin With Simvastatin (JUVISYNC): A New Drug Combination to Avoid
The article discusses the reasons why we have categorized JUVISYNC as a DO NOT USE drug.